Sign Up to like & get
recommendations!
0
Published in 2021 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2021.113812
Abstract: Chemokine receptor 2 (CXCR2) is the receptor of glutamic acid-leucine-arginine sequence-contained chemokines CXCs (ELR+ CXCs). In recent years, CXCR2-target treatment strategy has come a long way in cancer therapy. CXCR2 antagonists could block CXCLs/CXCR2 axis,…
read more here.
Keywords:
cxcr2;
one derivatives;
triazol one;
derivatives pyridazinone ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c01219
Abstract: Increasing evidence shows that the CXC chemokine receptor 2 (CXCR2) signaling pathway is essentially implicated in the recruitment of myeloid-derived suppressor cells (MDSCs) to the tumor microenvironment and leads to MDSC-mediated immune suppression. Therefore, CXCR2…
read more here.
Keywords:
potent cxcr2;
benzocyclic sulfone;
sulfone derivatives;
cancer immunotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Royal Society Open Science"
DOI: 10.1098/rsos.180176
Abstract: Metastatic cancer is considered a fatal progression of cancer worldwide. It has been shown that a key player in this scenario is the CXC chemokine receptor 2 (CXCR2). To identify novel CXCR2 antagonists, a pharmacophore…
read more here.
Keywords:
cxcr2;
novel cxcr2;
cancer;
anti cancer ... See more keywords